Metraipolis › archive › dc_cd285c2db031

Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer's Disease: A Methodological Approach — Europe PMC PMID:42201167

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42201167
DOI: 10.3390/mps9030074
License (as archived): solo-consultazione
Archived: 2026-11-02T13:48:07.290Z
SHA-256 of the archived text: 6109ba3044cb4b4c2671eeb2c11ef2841fc5760ce25eaf1d229509df948c36cd
Stable URL of this page: https://metraipolis.com/documento/dc_cd285c2db031

How to cite

Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer's Disease: A Methodological Approach — Europe PMC PMID:42201167 — Europe PMC (en), https://europepmc.org/article/MED/42201167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd285c2db031 (Metraipolis archive dc_cd285c2db031, sha256 6109ba3044cb4b4c2671eeb2c11ef2841fc5760ce25eaf1d229509df948c36cd)

BibTeX

@misc{dccd285c2db031,
  title = {Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer's Disease: A Methodological Approach — Europe PMC PMID:42201167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42201167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd285c2db031; sha256 6109ba3044cb4b4c2671eeb2c11ef2841fc5760ce25eaf1d229509df948c36cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42201167. Agents can read the archived copy with the MCP tool read_document.